SSW [Seaspan] 6-K: (Original Filing)
[Item 1 - Information Contained in this Form 6-K Report SEASPAN CORPORATION Sai W. Chu Chief Financial Officer]
OSN [Ossen Innovation] 6-K: (Original Filing)
[Ossen Innovation Announces Two New Steel Strand Supply Contracts for Bridge and Highway Infrastructure Projects in Anhui Province SHANGHAI, November 5, 2013 -- Ossen Innovation Co., Ltd. ("Ossen" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced that it has been awarded two contracts to] [FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA x ¨ Form 20-F ¨ x Yes OSSEN INNOVATION CO., LTD. Description 99.1 Press Release of Ossen Innovation Co., Ltd., dated November 5, 2013 6-K 1 v359194_6k.htm 6-K]
SSW [Seaspan] 6-K: Item 1 – Information Contained in this Form
[Item 1 - Information Contained in this Form 6-K Report SEASPAN CORPORATION Sai W. Chu Chief Financial Officer]
OSN [Ossen Innovation] 6-K: Ossen Innovation Announces Two New Steel Strand Supply
[Ossen Innovation Announces Two New Steel Strand Supply Contracts for Bridge and Highway Infrastructure Projects in Anhui Province SHANGHAI, November 5, 2013 -- Ossen Innovation Co., Ltd. ("Ossen" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced that it has been awarded two contracts to] [FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA x ¨ Form 20-F ¨ x Yes OSSEN INNOVATION CO., LTD. Description 99.1 Press Release of Ossen Innovation Co., Ltd., dated November 5, 2013 6-K 1 v359194_6k.htm 6-K]
SSW [Seaspan] 424B5: (Original Filing)
[ABOUT THIS PROSPECTUS SUPPLEMENT This document is in two parts. The first part is the prospectus supplement, which describes the specific terms of this offering. The second part is the accompanying base prospectus, which gives more general information, some of which may not apply to this offering. Generally, when we refer to the prospectus, we are referring to both parts]
CBPO [China Biologic Products] 8-K: FOR RELEASE November 5, 2013 China Biologic Reports
[FOR RELEASE November 5, 2013 China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2013 --3Q13 Total Sales of $53.2 Million / 9M Total Sales Up 6.6%-- --3Q13 Operating Income Up 13.4% / 9M Operating Income Up 23.0%-- --3Q13 Operating Margin Up 520 bp to 43.6% / 9M Operating Margin Up to 46.3% -- --3Q13] []
SSW [Seaspan] 424B5: ABOUT THIS PROSPECTUS SUPPLEMENT This document is in
[ABOUT THIS PROSPECTUS SUPPLEMENT This document is in two parts. The first part is the prospectus supplement, which describes the specific terms of this offering. The second part is the accompanying base prospectus, which gives more general information, some of which may not apply to this offering. Generally, when we refer to the prospectus, we are referring to both parts]
CBPO [China Biologic Products] 10-Q: (Original Filing)
[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [David (Xiaoying) Gao , the Chief Executive Officer of CHINA BIOLOGIC PRODUCTS, INC. (the “Company”), DOES HEREBY CERTIFY that: 1. September 30 , 201 3 2. 5 th day of November , 201 3 . David (Xiaoying) Gao Chief Executive Officer A signed original of this written statement required by Section 906 has been provided to China Biologic Products, Inc.] [Ming Yang , the Chief Financial Officer of CHINA BIOLOGIC PRODUCTS, INC. (the “Company”), DOES HEREBY CERTIFY that: 1. 3 2. 5 th day of November , 201 3 . Ming Yang Ming Yang Chief Financial Officer (Principal Financial Officer) A signed original of this written statement required by Section 906 has been provided to China Biologic Products, Inc. and]
EGT [Entertainment Gaming Asia] 8-K: (Original Filing)
[CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com 312/867-0848 RESULTS ENTERTAINMENT GAMING ASIA INC. REPORTS THIRD QUARTER 2013 AND PROVIDES MARKET UPDATE Hong Kong – November 5, 2013 – Entertainment Gaming Asia Inc. (NASDAQ: EGT) (“Entertainment Gaming Asia” or “the Company”), a leading gaming company focused on emerging gaming markets in Pan-Asia, today reported operating results for the third quarter] [ENTERTAINMENT GAMING ASIA INC. Nevada 001-32161 91-1696010 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification Number) Unit C1, Ground Floor, Koon Wah Building No. 2 Yuen Shun Circuit Yuen Chau Kok, Shatin New Territories, Hong Kong SAR + 852-3147-6600 Not applicable (Former name or former address, if changed since last report) o o o o Item 2.02 Results of]
CBPO [China Biologic Products] 10-Q:
[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [David (Xiaoying) Gao , the Chief Executive Officer of CHINA BIOLOGIC PRODUCTS, INC. (the “Company”), DOES HEREBY CERTIFY that: 1. September 30 , 201 3 2. 5 th day of November , 201 3 . David (Xiaoying) Gao Chief Executive Officer A signed original of this written statement required by Section 906 has been provided to China Biologic Products, Inc.] [Ming Yang , the Chief Financial Officer of CHINA BIOLOGIC PRODUCTS, INC. (the “Company”), DOES HEREBY CERTIFY that: 1. 3 2. 5 th day of November , 201 3 . Ming Yang Ming Yang Chief Financial Officer (Principal Financial Officer) A signed original of this written statement required by Section 906 has been provided to China Biologic Products, Inc. and]
